Noul, a leading innovator in AI-driven healthcare solutions, is set to debut its cutting-edge diagnostic platform, miLab, at CES 2025. The world’s largest technology and consumer electronics exhibition will take place from January 7 to 10 at the Las Vegas Convention Center, showcasing groundbreaking advancements in AI, digital healthcare, mobility, and more.
miLab: The Future of Diagnostics
The miLab platform is an AI-powered, fully automated digital microscope system that processes blood samples, generates high-resolution images, and provides AI-driven analyses—all in just 15 minutes. Featuring compact hardware and smart cartridges, miLab is designed for diverse medical environments, ensuring global adaptability for efficient diagnostics.
Recent Milestones
Noul recently achieved FDA Class 1 medical device registration for its key products, including:
miLab Platform
miLab Cartridge MAL
miLab Cartridge BCM
SafeFix
This regulatory milestone further validates Noul’s commitment to delivering innovative solutions to the global healthcare market.
